Atlantic International Corp. (ATLN) is a Technology stock trading at $1.29 (as of 2026-06-04), with a market capitalization of $105.55M and a trailing P/E of -1.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Atlantic International Corp. is a life sciences instrumentation and research services company focused on developing scientific assets and intellectual property, including its tSMS platform for single-molecule DNA and RNA sequencing. Its sequencing technology is used by academic, government, and industry research labs for applications such as biomarker discovery and diagnostic assay development, including research agreements with the FBI and the Weizmann Institute of Science.